UPDATE 1-Actelion re-enters talks with J&J in takeover twist

ZURICH, Dec 21 (Reuters) - The takeover battle surrounding

Actelion heated up on Wednesday when the Swiss biotech

company said it had begun exclusive talks with former suitor

Johnson & Johnson about a "strategic transaction".

Read more